TCM
BIO icon

Tygh Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Tygh Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,075
Closed -$7.78M – 92
2021
Q2 		$7.78M Sell
12,075
-132
-1% -$80.3K 1.06% 44
2021
Q1 		$6.97M Sell
12,207
-7,837
-39% -$4.64M 0.99% 43
2020
Q4 		$11.7M Sell
20,044
-2,969
-13% -$1.69M 1.82% 9
2020
Q3 		$11.9M Sell
23,013
-1,821
-7% -$922K 2.25% 8
2020
Q2 		$11.2M Sell
24,834
-23,690
-49% -$10.5M 2.34% 7
2020
Q1 		$17M Buy
48,524
+396
+0.8% +$146K 3.81% 1
2019
Q4 		$17.8M Buy
48,128
+5,102
+12% +$1.8M 2.94% 3
2019
Q3 		$14.3M Sell
43,026
-74
-0.2% -$24.1K 2.54% 5
2019
Q2 		$13.5M Buy
43,100
+1,187
+3% +$355K 2.29% 8
2019
Q1 		$12.8M Buy
+41,913
New +$11.3M 2.25% 5
2018
Q4 		– Sell
-33,014
Closed -$10.3M – 79
2018
Q3 		$10.3M Sell
33,014
-974
-3% -$302K 1.69% 18
2018
Q2 		$9.81M Buy
33,988
+12,317
+57% +$3.4M 1.66% 17
2018
Q1 		$5.42M Sell
21,671
-5,591
-21% -$1.42M 1.03% 46
2017
Q4 		$6.51M Sell
27,262
-637
-2% -$154K 1.22% 27
2017
Q3 		$6.2M Sell
27,899
-7,557
-21% -$1.7M 1.24% 35
2017
Q2 		$8.02M Buy
35,456
+4,461
+14% +$972K 1.82% 7
2017
Q1 		$6.18M Buy
30,995
+1,099
+4% +$212K 1.44% 17
2016
Q4 		$5.45M Buy
+29,896
New +$5.1M 1.37% 27

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tygh Capital Management's BIO Position: Q3 2021 in Review

Tygh Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2021, closing a stake of 12,075 shares — an estimated $7.78M sold.

Tygh Capital Management first reported a position in BIO in Q4 2016 and held it in 18 quarters. The position peaked at $17.8M in Q4 2019. 507 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

  • Tygh Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2021 after selling out during the quarter.
  • Tygh Capital Management sold 12,075 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $7.78M.
  • Tygh Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 18 quarters.
  • Tygh Capital Management's Bio-Rad Laboratories Class A position peaked at $17.8M in Q4 2019.
  • 507 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on Tygh Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.